What does CalciMedica, Inc. do?
CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel…
What is CalciMedica, Inc.'s P/E and P/B ratio?
CalciMedica, Inc. has a P/E ratio of -0.2 and a P/B ratio of 1.42.
What is CalciMedica, Inc.'s debt-to-equity ratio?
CalciMedica, Inc. has a debt-to-equity ratio of 1.67.
How much does CalciMedica, Inc. owe compared with what it owns?
CalciMedica, Inc. owes $0.72 for every $1 it owns (balance sheet Jun 2026), which is moderate.
What is CalciMedica, Inc.'s Positivity rank?
CalciMedica, Inc. is ranked #3,625 of 6,774 companies globally and #1,606 of 4,000 in United States on PositoAI, with a Positivity Score of 20,400.
Does CalciMedica, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
Yes. CalciMedica, Inc. has 1 active red flag (PosiRed) on record: Stock exchange listing-rule deficiency notice (8-K Item 3.01) (dated 18 Mar 2026). It has no yellow flags.
Where can I read the latest news about CalciMedica, Inc.?
Recent headlines about CalciMedica, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does CalciMedica, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of CalciMedica, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.